US$ 28.52
ipamorelin + epithalon + cjc-1295 no dac Blend: (No DAC) 20MG CJC-1295 (NO DAC) + IPAMORELIN
Description
Sweeney C, 2024, 'Association of the lipid biomarker, PCPro, and clinical outcomes in the ENZAMET trial (ANZUP 1304)', in ANNALS OF ONCOLOGY , ELSEVIER, SPAIN, Barcelona, Vol

Fruquintinib is a selective oral inhibitor of VEGFR-1-3, which is currently under investigation in numerous clinical trials

12 weeks (1x daily, 5-on/2-off) 4 vials 60 doses needed (5x12)

TZP binds its receptor, leading to the activation of adenylyl cyclase-cAMP-protein kinase A (PKA) pathway and thus stimulating glucose metabolism (glycolysis and Krebs Cycle)

Reconstitution: Glutathione is highly water-soluble

I'm so excited because we'll have her talk about that
